Related Experiment Video
Updated: Feb 16, 2026
03:22
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
1.6K
Infectious pleural effusion status and treatment progress
Wei Yang1, Bo Zhang1, Ze-Ming Zhang2
1Department of Respiratory Medicine, Medical School of Chinese PLA, Beijing 100853, China.
Journal of Thoracic Disease
|December 23, 2017
Summary
Pleural cavity infections require analysis of bacteria and biochemical features for effective treatment. Antibiotics and drainage are key, with surgery considered if conservative methods fail.
Area of Science:
- Medical Microbiology
- Pulmonology
- Infectious Diseases
Background:
- Pleural cavity infections pose a significant threat to human health.
- Pathophysiology involves three stages: exudative, fibrinopurulent, and organizational.
- Distinguishing pleural from pulmonary infections necessitates analyzing pleural effusion characteristics.
Purpose of the Study:
- To highlight the importance of analyzing bacterial and biochemical characteristics of pleural effusion for effective treatment of pleural cavity infections.
- To review current treatment strategies, including antibiotics, drainage, and surgical interventions.
- To emphasize the need for future research into prognosis, early evaluation, and stratification of patients.
Main Methods:
- Review of pathophysiology and clinical characteristics of pleural cavity infections.
- Analysis of diagnostic importance of pleural effusion properties.
- Evaluation of current therapeutic approaches, including medical and surgical options.
Main Results:
- Effective treatment relies on identifying pathogenic bacteria and biochemical markers in pleural effusion.
- Antibiotic therapy and adequate drainage form the cornerstone of management.
- Fibrinolytic agents lack routine evidence, but plasminogen activator and deoxyribonuclease show potential.
- Surgical options like thoracoscopy and decortication are reserved for treatment failures.
Conclusions:
- Accurate diagnosis and tailored treatment based on pleural effusion analysis are crucial for managing pleural infections.
- While most prognoses are favorable, complications like parapneumonic effusion and empyema require vigilant management.
- Further research into clinical characteristics is essential for improving patient prognosis and enabling early risk stratification.
Related Concept Videos
01:28Pleural Effusion II: Symptoms and Management
837
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
837
01:25Pleural Effusion I: Introduction
4.6K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.6K
01:28Pneumonia IV: Management
837
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
837
01:30Pneumonia III: Complications and Assessment
930
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
930
01:27Pneumothorax-II
1.1K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.1K
01:30Pneumonia V: Nursing management and Prevention
3.6K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K